185 related articles for article (PubMed ID: 37324481)
1. Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay.
Saecker L; Häberlein H; Franken S
Front Pharmacol; 2023; 14():1172551. PubMed ID: 37324481
[No Abstract] [Full Text] [Related]
2. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A
Soave M; Kellam B; Woolard J; Briddon SJ; Hill SJ
SLAS Discov; 2020 Feb; 25(2):186-194. PubMed ID: 31583945
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells.
Tsutsui S; Vergote D; Shariat N; Warren K; Ferguson SS; Power C
FASEB J; 2008 Mar; 22(3):786-96. PubMed ID: 17965263
[TBL] [Abstract][Full Text] [Related]
4. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells.
Lowther KM; Uliasz TF; Götz KR; Nikolaev VO; Mehlmann LM
PLoS One; 2013; 8(6):e65365. PubMed ID: 23826079
[TBL] [Abstract][Full Text] [Related]
7. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
[TBL] [Abstract][Full Text] [Related]
8. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
[TBL] [Abstract][Full Text] [Related]
9. Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
Zarca A; Perez C; van den Bor J; Bebelman JP; Heuninck J; de Jonker RJF; Durroux T; Vischer HF; Siderius M; Smit MJ
Cells; 2021 Mar; 10(3):. PubMed ID: 33799570
[No Abstract] [Full Text] [Related]
10. In-Cell Arrestin-Receptor Interaction Assays.
Zheng C; Javitch JA; Lambert NA; Donthamsetti P; Gurevich VV
Curr Protoc; 2023 Oct; 3(10):e890. PubMed ID: 37787634
[TBL] [Abstract][Full Text] [Related]
11. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
12. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives.
Storme J; Tosh DK; Gao ZG; Jacobson KA; Stove CP
Biochem Pharmacol; 2018 Dec; 158():103-113. PubMed ID: 30292756
[TBL] [Abstract][Full Text] [Related]
13. Nanoluciferase-based complementation assay for systematic profiling of GPCR-GRK interactions.
Palmer CB; D'Uonnolo G; Luís R; Meyrath M; Uchański T; Chevigné A; Szpakowska M
Methods Cell Biol; 2022; 169():309-321. PubMed ID: 35623709
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of the human A
Storme J; Cannaert A; Van Craenenbroeck K; Stove CP
Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.
Violin JD; Ren XR; Lefkowitz RJ
J Biol Chem; 2006 Jul; 281(29):20577-88. PubMed ID: 16687412
[TBL] [Abstract][Full Text] [Related]
16. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
17. Capadenoson, a clinically trialed partial adenosine A
Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Arrestin Recruitment to GPCRs.
Spillmann M; Thurner L; Romantini N; Zimmermann M; Meger B; Behe M; Waldhoer M; Schertler GFX; Berger P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668755
[TBL] [Abstract][Full Text] [Related]
19. Ivy leaves dry extract EA 575® mediates biased β
Meurer F; Schulte-Michels J; Häberlein H; Franken S
Phytomedicine; 2021 Sep; 90():153645. PubMed ID: 34280828
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells.
Gupta K; Subramanian H; Klos A; Ali H
PLoS One; 2012; 7(10):e46369. PubMed ID: 23077507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
